BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Feb 24, 2026; 17(2): 113674
Published online Feb 24, 2026. doi: 10.5306/wjco.v17.i2.113674
Perineural invasion in digestive tract tumors: Immune system interactions and therapeutic strategies
Jia-Yu Pang, Rong-Yao Jin, Han-Xiao Zhang, Ying-Hua Zhang, Xin-Yue Wei, Wen-Bo Cao, Yi-Xiao Chen, Jun-Ling Wang, Sai-Jun Mo
Jia-Yu Pang, Rong-Yao Jin, Han-Xiao Zhang, Ying-Hua Zhang, Xin-Yue Wei, Wen-Bo Cao, Yi-Xiao Chen, Sai-Jun Mo, Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, Henan Province, China
Jia-Yu Pang, The First Clinical College of Zhengzhou University, Zhengzhou University, Zhengzhou 450001, Henan Province, China
Jun-Ling Wang, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, Henan Province, China
Co-first authors: Jia-Yu Pang and Rong-Yao Jin.
Author contributions: Pang JY and Jin RY contributed to the work equally and are co-first authors of this manuscript; Pang JY and Jin RY wrote the draft; Zhang HX, Zhang YH, Wei XY, Cao WB, Chen YX, and Wang JL searched and collated the literature; Mo SJ designed and revised the manuscript; and all authors have read and approved the final manuscript.
Supported by the Foundation of Henan Educational Committee, No. 26A310017; the College Student Innovation and Entrepreneurship Competitions, No. S202510459221 and No. 2025cxcy639; the Natural Science Foundation of Henan, No. 242300421493; and the Medical Science and Technology Planning Project of Henan Province, No. LHGJ20220525.
Conflict-of-interest statement: Dr. Mo has a patent the Foundation of Henan Educational Committee (No. 26A310017) issued, a patent College Student Innovation and Entrepreneurship Competitions (No. 202510459174 and No. 2025cxcy639) issued; and Wang JL has a patent Natural Science Foundation of Henan (No. 242300431493) issued, and a patent the Medical Science and Technology Planning Project of Henan Province (No. LHGJ20220525) issued.
Corresponding author: Sai-Jun Mo, Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, No. 100 Science Avenue, Zhongyuan District, Zhengzhou 450001, Henan Province, China. sjmo@zzu.edu.cn
Received: September 2, 2025
Revised: October 24, 2025
Accepted: December 19, 2025
Published online: February 24, 2026
Processing time: 158 Days and 23.9 Hours
Abstract

Digestive tract tumors represent a substantial global public health challenge, accounting for elevated morbidity and mortality rates. Perineural invasion (PNI), the spread of tumor cells along nerve fibers, has emerged as a key driver of aggressiveness and a poor prognosis. This study systematically reviews the complex, underexplored interplay between PNI and antitumor immunity in gastrointestinal cancers. By analyzing immune-related components (the programmed cell death protein 1/programmed death ligand 1 axis, T cell subsets, tumor-associated macrophages, and other immune checkpoints), it reveals PNI disrupts immune balance: It suppresses T-cell activity via programmed death ligand 1/programmed cell death protein 1 binding, skews T-cell differentiation to reduce antitumor efficacy and boost immunosuppression, and polarizes macrophages to aid tumor progression. These findings provide novel insights into how PNI reshapes the tumor immune microenvironment and promotes metastatic behavior, establishing a framework for prioritizing immunotherapeutic targets to inform precision treatment strategies.

Keywords: Digestive tract tumors; Perineural invasion; Immune system; Tumor microenvironment; Immunotherapy

Core Tip: Digestive tract tumors remain a major global health burden with high morbidity and mortality. Perineural invasion (PNI), the infiltration of tumor cells along nerves, is a key determinant of tumor aggressiveness and poor outcome. This review systematically investigates the crosstalk between PNI and immune mechanisms in gastrointestinal cancers, with a focus on critical components, including the programmed cell ligand 1/programmed cell 1 axis, T cells, macrophages, and other immune checkpoints. It reveals mechanisms by which PNI reshapes the tumor immune microenvironment to promote metastasis, identify candidate immunotherapeutic targets, and provide a foundation for developing precision treatment strategies.